Correlation Between Keros Therapeutics and MAIA Biotechnology
Can any of the company-specific risk be diversified away by investing in both Keros Therapeutics and MAIA Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Keros Therapeutics and MAIA Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Keros Therapeutics and MAIA Biotechnology, you can compare the effects of market volatilities on Keros Therapeutics and MAIA Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Keros Therapeutics with a short position of MAIA Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Keros Therapeutics and MAIA Biotechnology.
Diversification Opportunities for Keros Therapeutics and MAIA Biotechnology
-0.15 | Correlation Coefficient |
Good diversification
The 3 months correlation between Keros and MAIA is -0.15. Overlapping area represents the amount of risk that can be diversified away by holding Keros Therapeutics and MAIA Biotechnology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on MAIA Biotechnology and Keros Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Keros Therapeutics are associated (or correlated) with MAIA Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of MAIA Biotechnology has no effect on the direction of Keros Therapeutics i.e., Keros Therapeutics and MAIA Biotechnology go up and down completely randomly.
Pair Corralation between Keros Therapeutics and MAIA Biotechnology
Given the investment horizon of 90 days Keros Therapeutics is expected to generate 0.52 times more return on investment than MAIA Biotechnology. However, Keros Therapeutics is 1.94 times less risky than MAIA Biotechnology. It trades about -0.07 of its potential returns per unit of risk. MAIA Biotechnology is currently generating about -0.06 per unit of risk. If you would invest 6,073 in Keros Therapeutics on August 29, 2024 and sell it today you would lose (334.00) from holding Keros Therapeutics or give up 5.5% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Keros Therapeutics vs. MAIA Biotechnology
Performance |
| Timeline |
| Keros Therapeutics |
| MAIA Biotechnology |
Keros Therapeutics and MAIA Biotechnology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Keros Therapeutics and MAIA Biotechnology
The main advantage of trading using opposite Keros Therapeutics and MAIA Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Keros Therapeutics position performs unexpectedly, MAIA Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in MAIA Biotechnology will offset losses from the drop in MAIA Biotechnology's long position.| Keros Therapeutics vs. Ideaya Biosciences | Keros Therapeutics vs. AnaptysBio | Keros Therapeutics vs. MeiraGTx Holdings PLC | Keros Therapeutics vs. Janux Therapeutics |
| MAIA Biotechnology vs. Lineage Cell Therapeutics | MAIA Biotechnology vs. Armata Pharmaceuticals | MAIA Biotechnology vs. Portage Biotech | MAIA Biotechnology vs. Larimar Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Other Complementary Tools
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Global Correlations Find global opportunities by holding instruments from different markets |